Diversified life sciences company Tauriga Sciences Inc (OTCMKTS:TAUG), which is based out of New York, has had a bit of a rollercoaster ride in recent times. This past Friday, the stock experienced a strong rally and ended up with gains of 7% to snap its losing streak.
Trading Data
On Friday, TAUG stock gained 7.17% to $0.0314 with more than 815K shares, compared to its average volume of 740k shares. The stock has moved within a range of $0.0291 – 0.0328 after opening trade at $0.0293.
Tauriga Sciences Inc. Formally Submits its Clinical Study Protocol to the Institutional Review Board
However, at the same time, it ought to be noted that the Tauriga stock is still down by as much as 16% over the past week. The stock rallied on Friday after the company announced that it had managed to complete the submission of its Clinical Study Protocol at the Institutional Review Board.
In this regard, it might also be important to note that the title of the protocol submitted by the company is “The Effect of CBD Gum on Nausea and Vomiting During Pregnancy”. It was a major development for the company and one that led to a lot of enthusiasm among investors. At this point in time, it is going to be interesting to see if the stock can continue to add to its gains over the course of this week and wipe out the declines that had been recorded in the past week.
Technical Data
TAUG stock is trading below the 20-Day and 50-Day Moving averages of $0.0377 and $0.0367 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0625. The stock is down 27% in the past week.
